Sandercock Brett's Form 4 filing
Resmed Inc (RMD) · filed Feb 22, 2023
- Accession no.
- 0001127602-23-006460
- Filed
- Feb 22, 2023
- Trade date
- Feb 17, 2023
- Filing delay
- 5 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $2.15M. It was filed 5 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sandercock BrettCIK 0001346064 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 17, 2023 | ResMed Common Stock | SSaleDisposed | −10,000 | $215.22F2 | −$2,152,200 | 106,880 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $215.00 - $215.59. The price reported above reflects the weighted average sale price.
Referenced by the price of 1 transaction in Table I.